CRON vs TRLV
Cronos Group Inc. and Trulieve Cannabis Corp., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CRON | TRLV |
|---|---|---|
| Revenue | $146.6M | $1.2B |
| Net income | $-9.4M | $-122.2M |
| Gross margin | 42.8% | 60.2% |
| Net margin | −6.4% | −10.3% |
| Return on equity | −0.9% | — |
| Diluted EPS | −$0.02 | −$0.58 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $149,000 | $228.6M |
| Equity | $1.1B | — |
| Net debt / equity | — | — |
| Current ratio | 19.59× | 4.43× |
| Revenue CAGR 5y | 25.7% | 17.8% |
| Profit CAGR 5y | — | — |
TRLV bills 8.1× the revenue of CRON, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
7 years side by side
| Fiscal year | CRON | TRLV |
|---|---|---|
| FY2025 | $146.6M | $1.2B |
| FY2024 | $117.6M | $1.2B |
| FY2023 | $87.2M | $1.1B |
| FY2022 | $86.7M | $1.2B |
| FY2021 | $64.6M | $931.9M |
| FY2020 | $46.7M | $521.5M |
| FY2019 | $23.8M | $252.8M |
Net income by year
Bottom line
| Fiscal year | CRON | TRLV |
|---|---|---|
| FY2025 | $-9.4M | $-122.2M |
| FY2024 | $41.1M | $-160.6M |
| FY2023 | $-74.0M | $-533.1M |
| FY2022 | $-168.7M | $-252.7M |
| FY2021 | $-396.1M | $17.4M |
| FY2020 | $-73.1M | $63.0M |
| FY2019 | $1.2B | $53.1M |
Advertisement
AdSense · Rectangle 336×280
More in this industry